GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 77 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,040 | +33.3% | 12,000 | 0.0% | 0.02% | +42.9% |
| Q2 2023 | $17,280 | -31.4% | 12,000 | 0.0% | 0.01% | -36.4% |
| Q1 2023 | $25,200 | +85.8% | 12,000 | 0.0% | 0.02% | +175.0% |
| Q4 2022 | $13,560 | -32.2% | 12,000 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $20,000 | +25.0% | 12,000 | 0.0% | 0.01% | +42.9% |
| Q2 2022 | $16,000 | -15.8% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $19,000 | -24.0% | 12,000 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $25,000 | -46.8% | 12,000 | 0.0% | 0.01% | -47.1% |
| Q3 2021 | $47,000 | +23.7% | 12,000 | 0.0% | 0.02% | +21.4% |
| Q2 2021 | $38,000 | +46.2% | 12,000 | 0.0% | 0.01% | +40.0% |
| Q1 2021 | $26,000 | -7.1% | 12,000 | -4.6% | 0.01% | 0.0% |
| Q4 2020 | $28,000 | -12.5% | 12,575 | +4.8% | 0.01% | -23.1% |
| Q3 2020 | $32,000 | -13.5% | 12,000 | 0.0% | 0.01% | -23.5% |
| Q2 2020 | $37,000 | – | 12,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $248,617 | 0.07% |
| Geneos Wealth Management Inc. | 417,350 | $801,312 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $23,040 | 0.02% |
| RETIREMENT GUYS FORMULA LLC | 11,500 | $22,080 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $36,981 | 0.01% |
| OSAIC HOLDINGS, INC. | 3,275,192 | $6,288,345 | 0.01% |
| Traynor Capital Management, Inc. | 34,707 | $66,638 | 0.01% |
| Atria Wealth Solutions, Inc. | 259,800 | $498,816 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $9,569 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $353,016 | 0.01% |